SCCM Pod-400 Are AKI Biomarkers Ready for Clinical Use
Kyle B. Enfield, MD, FCCM, and Azra Bihorac, MD, MS, FCCM, discuss best practices and complexities of implementing biomarkers for kidney stress and acute kidney injury (AKI) and what the future holds for AKI biomarker literature. Dr. Bihorac was a presenter on this topic at the Society’s 48th Critical Care Congress. Dr. Bihorac is the R. Glenn Davis professor of medicine, surgery, and anesthesiology in the division of nephrology, hypertension, and renal transplant within the department of medicine at the University of Florida in Gainesville, Florida, USA. This podcast is part 4 of a series sponsored by Baxter Healthcare Corporation.
Published: 11/20/2019 . Source Page